RC

Rockmore Capital

North America, New York, United States, New York

Description

Rockmore Capital is an investment advisory firm that is headquartered in New York, United States.

Investor Profile

Rockmore Capital has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 2 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Post Ipo Equity, Series Unknown rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Medical.

Stage Focus

  • Post Ipo Equity (50%)
  • Series Unknown (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Medical
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Rockmore Capital frequently co-invest with?

DC
North America, Illinois, United States, Deerfield
Co-Investments: 1
Iroquois Capital
North America, Tennessee, United States, Nashville
Co-Investments: 2
WC
North America, Ontario, Canada, Toronto
Co-Investments: 1
Dafna Capital Management
North America, California, United States, Los Angeles
Co-Investments: 1
Alpha Capital
North America, Illinois, United States, Chicago
Co-Investments: 1
Paramount BioCapital Asset Management
North America, New York, United States, New York
Co-Investments: 1
Midsummer Capital
North America, New York, United States, New York
Co-Investments: 1
ArmaVir Partners
North America, New York, United States, New York
Co-Investments: 1
BC
North America, New York, United States, New York
Co-Investments: 1
KC
Europe, England, United Kingdom, London
Co-Investments: 1

What are some of recent deals done by Rockmore Capital?

Soligenix

Princeton, New Jersey, United States

Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.

BiopharmaBiotechnologyHealth CareMedical
Series UnknownJul 2, 2010
Amount Raised: $5,904,277
CEL-SCI

Vienna, Virginia, United States

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

BiotechnologyHealth CareMedical
Post Ipo EquityAug 20, 2009
Amount Raised: $4,400,000